BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24890200)

  • 21. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
    Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
    Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic difficulties in glucokinase hyperinsulinism.
    Meissner T; Marquard J; Cobo-Vuilleumier N; Maringa M; Rodríguez-Bada P; García-Gimeno MA; Baixeras E; Weber J; Olek K; Sanz P; Mayatepek E; Cuesta-Muñoz AL
    Horm Metab Res; 2009 Apr; 41(4):320-6. PubMed ID: 19053014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
    Beer NL; van de Bunt M; Colclough K; Lukacs C; Arundel P; Chik CL; Grimsby J; Ellard S; Gloyn AL
    J Biol Chem; 2011 May; 286(21):19118-26. PubMed ID: 21454522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
    Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
    J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Maturity-onset diabetes of the young 2 with a novel mutation of glucokinase gene in a Chinese boy and the clinical follow-up].
    Li X; Liu L; Liang C; Sheng H; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):867-71. PubMed ID: 25582477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
    Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
    Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperglycemia caused by mutation of GCK gene in 10 patients analysis of clinical and mutation characteristics].
    Zhang J; Yuan K; Ding SX; Kong YM; Zhu JF; Fang YL; Liang L; Fu JF; Wang CL
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):440-444. PubMed ID: 31216801
    [No Abstract]   [Full Text] [Related]  

  • 29. Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes.
    Tornovsky-Babeay S; Weinberg-Corem N; Ben-Haroush Schyr R; Avrahami D; Lavi J; Feleke E; Kaestner KH; Dor Y; Glaser B
    Diabetologia; 2021 May; 64(5):1133-1143. PubMed ID: 33558985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
    Steele AM; Wensley KJ; Ellard S; Murphy R; Shepherd M; Colclough K; Hattersley AT; Shields BM
    PLoS One; 2013; 8(6):e65326. PubMed ID: 23799006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor.
    Murphy R; Tura A; Clark PM; Holst JJ; Mari A; Hattersley AT
    Diabetologia; 2009 Jan; 52(1):154-9. PubMed ID: 18974968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations.
    Sayed S; Langdon DR; Odili S; Chen P; Buettger C; Schiffman AB; Suchi M; Taub R; Grimsby J; Matschinsky FM; Stanley CA
    Diabetes; 2009 Jun; 58(6):1419-27. PubMed ID: 19336674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
    Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus.
    Hussain K
    Rev Endocr Metab Disord; 2010 Sep; 11(3):179-83. PubMed ID: 20878480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical heterogeneity in monogenic diabetes caused by mutations in the glucokinase gene (GCK-MODY).
    Cuesta-Muñoz AL; Tuomi T; Cobo-Vuilleumier N; Koskela H; Odili S; Stride A; Buettger C; Otonkoski T; Froguel P; Grimsby J; Garcia-Gimeno M; Matschinsky FM
    Diabetes Care; 2010 Feb; 33(2):290-2. PubMed ID: 19903754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
    Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
    PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.